Press Releases

LOS ANGELES, May 31, 2024 /PRNewswire/ -- Ervin Cohen & Jessup LLP announced today that Partners Amy Russell and Cate Veeneman have been recognized by the Los Angeles Business Journal in its "Women of Influence: Attorneys" special edition. "The women covered in these pages have been recognized for exceptional legal skill and achievement across the full spectrum of responsibility, exemplary leadership as evidenced by the highest professional and ethical standards,... (continue reading...)

Collaborates with Arista Networks, Intel Corporation and joins Ultra Ethernet Consortium

SEATTLE--(BUSINESS WIRE)-- First paragraph, first sentence of release should read: Today, Qumulo, the simple way to manage exabyte-scale data anywhere, became the first Networked Storage supplier to join the Ultra Ethernet Consortium.

The updated release reads:

QUMULO’S DATA PLATFORM EMBRACES NEXT-GENERATION OF NETWORKING

Collaborates with Arista Networks, Intel... (continue reading...)

Massapequa's Paul Carey DDS Gives Back With Scholarship Fund

Massapequa, New York, United States - May 31, 2024 —

The esteemed Dr. Paul Carey Scholarship for Medical Students is now accepting applications, offering a unique opportunity for aspiring medical professionals to gain recognition and financial support. This annual scholarship, founded in honor of Dr Paul Carey DDS Massapequa New York, aims to nurture academic excellence and a commitment to healthcare,... (continue reading...)

Trendex Redefines Human Talent Tokenization: Acquiring Gummys to Fuel U.S. Growth and Tokenize Creators

Paris, Ile-de-France, France - May 31, 2024 —

Trendex, the leading European company in athlete tokenization, backed by Y Combinator, is excited to embark on a new phase of its development. Having raised over $4 million from European and Asian investors, including Real Madrid’s "Ballon d’Or" winner and international football star Karim Benzema, and built a... (continue reading...)

mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes

CAMBRIDGE, MA / ACCESSWIRE / May 31, 2024 / Moderna, Inc. (NASDAQ: MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine, to protect adults aged 60 years and older from lower respiratory tract disease caused by RSV infection. The approval was granted under a... (continue reading...)